Swara Baby Files DRHP for ₹1,000 Crore IPO to Fuel Expansion
India’s leading contract manufacturer of disposable hygiene products, Swara Baby, has officially filed its Draft Red Herring Prospectus (DRHP) with SEBI. The company aims to raise ₹1,000 crore through an initial public offering to scale its manufacturing capabilities and strengthen its market leadership.
IPO Structure and Utilization of Funds
The proposed ₹1,000 crore IPO is divided into two equal components: a fresh issue of equity shares worth up to ₹500 crore and an Offer for Sale (OFS) of up to ₹500 crore. Within the OFS, Brainbees Solutions Limited will sell shares worth up to ₹300 crore, while Anadya Bon Merchari LLP will divest up to ₹200 crore.
Swara Baby has outlined a clear roadmap for the fresh issue proceeds. A significant portion, ₹198.2 crore, is earmarked for establishing a new manufacturing facility in Madhya Pradesh. The company also plans to utilize ₹100 crore to repay or prepay existing borrowings and ₹27.5 crore to settle debt within its subsidiaries: Solis Hygiene, Swara Hygiene, and K.A. Enterprises Hygiene Private Limited (KAEHPL). The remaining funds will be directed toward inorganic growth through strategic acquisitions and general corporate purposes.
Market Dominance in Hygiene Manufacturing
Founded in 2018, Swara Baby has rapidly ascended to become India's largest contract manufacturer of disposable hygiene products by value in FY25. The company holds a commanding 37% market share in the baby diaper contract manufacturing segment and an estimated 36% share in the adult diaper segment.
The company’s manufacturing prowess is backed by four facilities across 24 acres in Pithampur and Indore, Madhya Pradesh. With 20 production lines, its annual installed capacity is massive: 2.66 billion baby diapers, 253 million adult diapers/period panties, and 756 million sanitary napkins. Beyond contract manufacturing for giants like Himalaya Wellness Company and Piramal Pharma, Swara Baby also operates its own brands, including Cuddles (baby diapers) and Shield (adult diapers).
Robust Financial Performance and Growth Trajectory
Swara Baby’s financial metrics indicate strong upward momentum. In FY26, the company reported revenue from operations of ₹1,163.9 crore, a significant jump from ₹942.97 crore in FY25 and ₹749.96 crore in FY24. Profit after tax (PAT) also saw an increase, reaching ₹95.58 crore in FY26 compared to ₹80.67 crore in the previous year.
The revenue mix is heavily driven by baby diapers, which accounted for 79.06% of product sales (₹911.81 crore) in FY26. Adult incontinence products contributed 16.07% (₹185.35 crore), while feminine hygiene products contributed 2.72% (₹31.35 crore).
As India's hygiene market is projected to grow at a 12.7% CAGR, Swara Baby is positioning itself to capture this demand through R&D innovation—such as their patent-pending plant-based "Tree Free" diapers—and aggressive capacity expansion.
Key Takeaways
- IPO Details: The ₹1,000 crore issue consists of a ₹500 crore fresh issue and a ₹500 crore Offer for Sale (OFS).
- Expansion Plans: Proceeds will primarily fund a new ₹198.2 crore manufacturing plant in Madhya Pradesh and debt repayment.
- Market Leadership: The company holds a dominant market share in both baby (37%) and adult (36%) diaper contract manufacturing.